Singapore

Deciphering complex biology with NetMAPPR platform, integrating data science, machine learning, high-throughput experiments, combinatorial genetics, and drug discovery, to yield promising drug targets for precision oncology therapeutics. 

US2.AI (formerly eko.ai) is automating the fight against heart disease, using AI software to simplify and democratize ultrasound of the heart, the most commonly used tool for the detection of cardiovascular risk.

Nuevocor is a Singapore-based biotechnology company that develops gene therapies to restore heart function in genetic cardiac diseases.

MiRXES is a leading developer of RNA-powered tests for disease early detection, with strong pipelines in multiple cancer types, as well as in cardiovascular, metabolic and infectious diseases. MiRXES is headquartered in Singapore, with operations in China, Japan and the United States, as well as commercial activities in over 45 countries globally.

Hummingbird Bioscience is a clinical-stage biotech company founded in 2015 by a team of interdisciplinary scientists with a shared belief that there is a better way to deliver a new generation of transformative precision medicines.

Launched in 2017, Doctor Anywhere is a regional tech-led healthcare company that harnesses the power of technology and connectivity, to combine a holistic range of health and wellness services into a single, integrated platform.

Biofourmis is a fast-growing global health IT company founded in Singapore that augments personalized patient care and therapies with Digital Therapeutics for better management of patients with complex chronic conditions.